Innovation

Tech behemoth Microsoft unveiled two new chips designed for artificial intelligence.

The drug is similar to Ozempic, which is commonly used for diabetes and weight loss.

With all eyes on generative AI (GenAI) this year, Australian executives are scrambling to makes sense of how the technology can create actual value in their organisations. All while assessing what’s still an unclear risk profile, as well as learning the basics of the underlying technology itself.

Microsoft-and-Google-backed artificial intelligence firm, OpenAI, held its first-ever DevDay on Monday November 6th, unveiling a slew of new developer products. One of those will allow users to create their own ‘GPTs’. In a blog post, OpenAI revealed it would roll out custom versions of its flagship generative AI products, ChatGPT, called GPTs. These GPTs could […]

Musk debuted xAI’s AI chatbot Grok over the weekend, though it is in a “very early beta” stage and only available to certain X subscribers.

Meta Group Industry Director Naomi Shepherd says it is never too late for parents to start a conversation with their children about social media usage – even if they’ve been on it for years. Shepherd said it was not too late to open up such conversations – even if a teenager had been on social […]

Rumored to be in the works for the past year, the initiative appears to have begun rolling out recently, with email solicitations being sent to potential buyers.

“What is in a name?” Shakespeare famously asked in 1581 when he penned ‘Romeo and Juliet’? A lot, it seems and especially if like me, you have a pesky apostrophe in yours.

The man received a pig heart last month and initially made “significant progress.”

Subscriptions will be available for any user over 18, while Meta explores providing younger users with a “useful and responsible ad experience.”